Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Zhejiang Provincial People's Hospital
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Immatics US, Inc.
GC Cell Corporation
Acepodia Biotech, Inc.
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
M.D. Anderson Cancer Center
Technical University of Munich
City of Hope Medical Center
Cancer Research UK